Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2007 | 12-2006 | 09-2006 | 06-2006 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,450 | -9,390 | -5,926 | -3,427 | -1,559 |
| Depreciation Amortization | 132 | 502 | 314 | 203 | 98 |
| Accounts receivable | -886 | -1,031 | -579 | -638 | -383 |
| Other Working Capital | -1,020 | 262 | -51 | -482 | -345 |
| Other Operating Activity | 2,368 | 4,566 | 2,940 | 2,061 | 1,052 |
| Operating Cash Flow | $-2,856 | $-5,091 | $-3,302 | $-2,283 | $-1,137 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -47 | N/A | N/A | N/A |
| PPE Investments | -512 | -842 | -639 | -430 | -183 |
| Other Investing Activity | -22 | -91 | -78 | -55 | -24 |
| Investing Cash Flow | $-534 | $-980 | $-717 | $-485 | $-207 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,910 | 16,367 | 14,899 | 30 | -4 |
| Other Financing Activity | -39 | 341 | 0 | 0 | 0 |
| Financing Cash Flow | $12,871 | $16,708 | $14,899 | $30 | $-4 |
| Exchange Rate Effect | 37 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 15,378 | 4,741 | 4,741 | 4,741 | 4,741 |
| End Cash Position | 24,896 | 15,378 | 15,621 | 2,003 | 3,393 |
| Net Cash Flow | $9,518 | $10,637 | $10,880 | $-2,738 | $-1,348 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,856 | -5,091 | -3,302 | -2,283 | -1,137 |
| Capital Expenditure | -516 | -842 | -639 | -430 | -183 |
| Free Cash Flow | -3,372 | -5,933 | -3,941 | -2,713 | -1,320 |